Quant Healthcare Fund - Growth - Regular Plan

Other Plans and Options
  • (-0.97%)Nav, as on 09-01-2026

  • Previous Nav

  • Net Change on 09-01-2026

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to seek long term capital appreciation by investing in equity/equity related instruments of companies from the healthcare sector. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
Nifty Healthcare Index - TRI N/A N/A N/A N/A N/A N/A

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option Jul 13, 2018 -0.05 26.84 16.74 1.86 6,455.55
Tata India Pharma & Healthcare Fund-Regular Plan-Growth Dec 28, 2015 -3.42 21.66 14.30 2.10 1,310.50
UTI Healthcare Fund - Regular Plan - Growth Option Aug 01, 2005 -3.07 23.52 14.03 2.27 1,101.63

Fund Holdings as on 31-December-2025

  • Cipla Limited

  • SMS Pharmaceuticals Limited

  • Sequent Scientific Limited

  • Zydus Wellness Ltd

  • Aster DM Healthcare Limited

  • Aurobindo Pharma Limited

  • Pfizer Ltd

  • Alivus Life Sciences

  • ANTHEM BIOSCIENCES LIMITED

  • Adani Enterprises Limited

  • TREPS 01-Jan-2026 DEPO 10

  • Samvardhana Motherson International Ltd

  • Divi's Laboratories Limited

  • Concord Biotech Limited

  • Divi's Laboratories Limited 27/01/2026

  • Biocon Ltd 27/01/2026

  • Apollo Hospitals Enterprise Ltd 27/01/2026

  • 182 Days Treasury Bill 29-Jan-2026

  • Aurobindo Pharma Limited 27/01/2026

  • Tech Mahindra Limited 27/01/2026

  • Gland Pharma Limited

  • 91 Days Treasury Bill 02-Jan-2026

  • 91 Days Treasury Bill 15-Jan-2026

  • 91 Days Treasury Bill 26-Feb-2026

  • 91 Days Treasury Bill 23-Jan-2026

  • 91 Days Treasury Bill 27-Mar-2026

  • Adani Enterprises Limited PP RE

  • 91 Days Treasury Bill 06-Feb-2026

  • 91 Days Treasury Bill 05-Mar-2026

  • NCA-NET CURRENT ASSETS

View More

  • Pharmaceuticals & Drugs

  • Miscellaneous

  • Consumer Food

  • Hospital & Healthcare Services

  • Trading

  • Auto Ancillary

View More

Fund Manager

  • Cash

  • Derivatives

  • Equity

  • Rights

  • SOV

View More

About Quant Healthcare Fund

Scheme Analysis

Quant Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Quant Mutual Fund. It was launched on 17-Jul-2023 and currently has an AUM of ₹362.34 crore. Quant Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and Nifty Healthcare Index - TRI as secondary index.

The NAV of Quant Healthcare Fund ended down ₹-0.15(-0.97%)yesterday to ₹14.8464.

Among its top 3 holdings the fund has exposure to Cipla Limited, and

The Quant Healthcare Fund is managed by Ankit Pande and Sandeep Tandon.

Fund House Contact

6th Floor, Sea Breeze Building, Appa Saheb Marathe Marg, Prabhadevi, Mumbai - 400025

022-6295 5000
help@quant.in
022-6295 5000